ID   APOB_RAT                Reviewed;        4743 AA.
AC   Q7TMA5;
DT   10-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   02-OCT-2024, entry version 145.
DE   RecName: Full=Apolipoprotein B-100;
DE            Short=Apo B-100;
DE   Contains:
DE     RecName: Full=Apolipoprotein B-48;
DE              Short=Apo B-48;
DE   Flags: Precursor;
GN   Name=Apob; ORFNames=Aa1064, Ac1-060;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Xu C.S., Li W.Q., Li Y.C., Wang G.P., Chai L.Q., Yuan J.Y., Yang K.J.,
RA   Yan H.M., Chang C.F., Zhao L.F., Ma H., Wang L., Wang S.F., Han H.P.,
RA   Shi J.B., Rahman S., Wang Q.N., Zhang J.B.;
RT   "Liver regeneration after PH.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=632283; DOI=10.1016/s0021-9258(17)40852-0;
RA   Wu A.L., Windmueller H.G.;
RT   "Identification of circulating apolipoproteins synthesized by rat small
RT   intestine in vivo.";
RL   J. Biol. Chem. 253:2525-2528(1978).
RN   [3]
RP   CHARACTERIZATION, AND RNA EDITING.
RX   PubMed=6948299; DOI=10.1073/pnas.79.1.179;
RA   Van't Hooft F.M., Hardman D.A., Kane J.P., Havel R.J.;
RT   "Apolipoprotein B (B-48) of rat chylomicrons is not a precursor of the
RT   apolipoprotein of low density lipoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:179-182(1982).
RN   [4]
RP   RNA EDITING.
RX   PubMed=2911593; DOI=10.1073/pnas.86.2.500;
RA   Tennyson G.E., Sabatos C.A., Higuchi K., Meglin N., Brewer H.B. Jr.;
RT   "Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular
RT   weight isoproteins in rat liver and intestine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:500-504(1989).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2006, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Apolipoprotein B is a major protein constituent of
CC       chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-
CC       100 functions as a recognition signal for the cellular binding and
CC       internalization of LDL particles by the apoB/E receptor.
CC       {ECO:0000269|PubMed:632283}.
CC   -!- SUBUNIT: Interacts with PCSK9. Interacts with MTTP. Interacts with AUP1
CC       (By similarity). Interacts with CIDEB (By similarity).
CC       {ECO:0000250|UniProtKB:E9Q414, ECO:0000250|UniProtKB:P04114}.
CC   -!- INTERACTION:
CC       Q7TMA5; P04639: Apoa1; NbExp=2; IntAct=EBI-15185298, EBI-2925493;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P04114}.
CC       Secreted {ECO:0000269|PubMed:632283}. Lipid droplet
CC       {ECO:0000250|UniProtKB:P04114}.
CC   -!- TISSUE SPECIFICITY: Detected in intestine and liver (at protein level).
CC       {ECO:0000269|PubMed:632283}.
CC   -!- PTM: Palmitoylated; structural requirement for proper assembly of the
CC       hydrophobic core of the lipoprotein particle. {ECO:0000250}.
CC   -!- RNA EDITING: Modified_positions=2147 {ECO:0000269|PubMed:2911593};
CC       Note=The stop codon (UAA) at position 2147 is created by an APOBEC1-
CC       containing mRNA editing complex. Apo B-48, derived from the fully
CC       edited RNA, is produced only in the intestine and is found in
CC       chylomicrons. Apo B-48 is a shortened form of apo B-100 which lacks the
CC       LDL-receptor region. The unedited version (apo B-100) is produced by
CC       the liver and is found in the VLDL and LDL.
CC       {ECO:0000269|PubMed:2911593, ECO:0000269|PubMed:6948299};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY318958; AAP85369.1; -; mRNA.
DR   EMBL; AY321317; AAP86249.1; -; mRNA.
DR   RefSeq; NP_062160.2; NM_019287.2.
DR   SMR; Q7TMA5; -.
DR   BioGRID; 248449; 1.
DR   DIP; DIP-29910N; -.
DR   IntAct; Q7TMA5; 20.
DR   STRING; 10116.ENSRNOP00000039779; -.
DR   CarbonylDB; Q7TMA5; -.
DR   GlyCosmos; Q7TMA5; 21 sites, No reported glycans.
DR   GlyGen; Q7TMA5; 21 sites.
DR   iPTMnet; Q7TMA5; -.
DR   PhosphoSitePlus; Q7TMA5; -.
DR   jPOST; Q7TMA5; -.
DR   PaxDb; 10116-ENSRNOP00000039779; -.
DR   GeneID; 54225; -.
DR   KEGG; rno:54225; -.
DR   AGR; RGD:2129; -.
DR   CTD; 338; -.
DR   RGD; 2129; Apob.
DR   VEuPathDB; HostDB:ENSRNOG00000005542; -.
DR   eggNOG; KOG0654; Eukaryota.
DR   eggNOG; KOG4338; Eukaryota.
DR   InParanoid; Q7TMA5; -.
DR   OrthoDB; 5349904at2759; -.
DR   PhylomeDB; Q7TMA5; -.
DR   TreeFam; TF331316; -.
DR   Reactome; R-RNO-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-RNO-3000471; Scavenging by Class B Receptors.
DR   Reactome; R-RNO-3000480; Scavenging by Class A Receptors.
DR   Reactome; R-RNO-3000497; Scavenging by Class H Receptors.
DR   Reactome; R-RNO-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-RNO-432142; Platelet sensitization by LDL.
DR   Reactome; R-RNO-5686938; Regulation of TLR by endogenous ligand.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8866423; VLDL assembly.
DR   Reactome; R-RNO-8957275; Post-translational protein phosphorylation.
DR   Reactome; R-RNO-8963888; Chylomicron assembly.
DR   Reactome; R-RNO-8963901; Chylomicron remodeling.
DR   Reactome; R-RNO-8964026; Chylomicron clearance.
DR   Reactome; R-RNO-8964038; LDL clearance.
DR   Reactome; R-RNO-8964046; VLDL clearance.
DR   Reactome; R-RNO-9707616; Heme signaling.
DR   Reactome; R-RNO-975634; Retinoid metabolism and transport.
DR   PRO; PR:Q7TMA5; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000005542; Expressed in liver and 12 other cell types or tissues.
DR   ExpressionAtlas; Q7TMA5; baseline and differential.
DR   GO; GO:0042627; C:chylomicron; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0070971; C:endoplasmic reticulum exit site; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:RGD.
DR   GO; GO:0034364; C:high-density lipoprotein particle; IDA:RGD.
DR   GO; GO:0034363; C:intermediate-density lipoprotein particle; ISO:RGD.
DR   GO; GO:0005811; C:lipid droplet; IEA:UniProtKB-SubCell.
DR   GO; GO:0034362; C:low-density lipoprotein particle; IDA:RGD.
DR   GO; GO:0034359; C:mature chylomicron; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0034361; C:very-low-density lipoprotein particle; IDA:RGD.
DR   GO; GO:0031983; C:vesicle lumen; IDA:RGD.
DR   GO; GO:0120020; F:cholesterol transfer activity; ISO:RGD.
DR   GO; GO:0008201; F:heparin binding; ISO:RGD.
DR   GO; GO:0035473; F:lipase binding; ISO:RGD.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; ISO:RGD.
DR   GO; GO:0005543; F:phospholipid binding; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISO:RGD.
DR   GO; GO:0071379; P:cellular response to prostaglandin stimulus; IEP:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0033344; P:cholesterol efflux; ISO:RGD.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; ISO:RGD.
DR   GO; GO:0030301; P:cholesterol transport; ISO:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0009566; P:fertilization; ISO:RGD.
DR   GO; GO:0030317; P:flagellated sperm motility; ISO:RGD.
DR   GO; GO:0001701; P:in utero embryonic development; ISO:RGD.
DR   GO; GO:0016042; P:lipid catabolic process; ISO:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; ISO:RGD.
DR   GO; GO:0042159; P:lipoprotein catabolic process; ISO:RGD.
DR   GO; GO:0042157; P:lipoprotein metabolic process; ISO:RGD.
DR   GO; GO:0042953; P:lipoprotein transport; ISO:RGD.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; ISO:RGD.
DR   GO; GO:0034374; P:low-density lipoprotein particle remodeling; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0010886; P:positive regulation of cholesterol storage; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0010884; P:positive regulation of lipid storage; ISO:RGD.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISO:RGD.
DR   GO; GO:0009791; P:post-embryonic development; ISO:RGD.
DR   GO; GO:0045540; P:regulation of cholesterol biosynthetic process; ISO:RGD.
DR   GO; GO:0009743; P:response to carbohydrate; IDA:RGD.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0010269; P:response to selenium ion; IEP:RGD.
DR   GO; GO:0009615; P:response to virus; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0019433; P:triglyceride catabolic process; IMP:RGD.
DR   GO; GO:0006642; P:triglyceride mobilization; ISO:RGD.
DR   CDD; cd20521; CYCLIN_CCNF_rpt1; 1.
DR   Gene3D; 1.10.472.10; Cyclin-like; 2.
DR   Gene3D; 2.20.80.10; Lipovitellin-phosvitin complex, chain A, domain 4; 1.
DR   Gene3D; 1.25.10.20; Vitellinogen, superhelical; 1.
DR   InterPro; IPR022176; ApoB100_C.
DR   InterPro; IPR052418; Apolipoprotein_B.
DR   InterPro; IPR013763; Cyclin-like_dom.
DR   InterPro; IPR036915; Cyclin-like_sf.
DR   InterPro; IPR006671; Cyclin_N.
DR   InterPro; IPR015819; Lipid_transp_b-sht_shell.
DR   InterPro; IPR009454; Lipid_transpt_open_b-sht.
DR   InterPro; IPR011030; Lipovitellin_superhlx_dom.
DR   InterPro; IPR015816; Vitellinogen_b-sht_N.
DR   InterPro; IPR015255; Vitellinogen_open_b-sht.
DR   InterPro; IPR001747; Vitellogenin_N.
DR   PANTHER; PTHR13769; APOLIPOPROTEIN B; 1.
DR   PANTHER; PTHR13769:SF1; APOLIPOPROTEIN B-100; 1.
DR   Pfam; PF12491; ApoB100_C; 1.
DR   Pfam; PF00134; Cyclin_N; 1.
DR   Pfam; PF06448; DUF1081; 1.
DR   Pfam; PF09172; Vit_open_b-sht; 1.
DR   Pfam; PF01347; Vitellogenin_N; 1.
DR   SMART; SM00385; CYCLIN; 1.
DR   SMART; SM01169; DUF1943; 1.
DR   SMART; SM00638; LPD_N; 1.
DR   SUPFAM; SSF47954; Cyclin-like; 2.
DR   SUPFAM; SSF48431; Lipovitellin-phosvitin complex, superhelical domain; 1.
DR   PROSITE; PS51211; VITELLOGENIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Atherosclerosis; Cholesterol metabolism; Chylomicron;
KW   Cytoplasm; Disulfide bond; Glycoprotein; Heparin-binding; LDL;
KW   Lipid droplet; Lipid metabolism; Lipid transport; Lipoprotein; Palmitate;
KW   Phosphoprotein; Reference proteome; RNA editing; Secreted; Signal;
KW   Steroid metabolism; Sterol metabolism; Transport; VLDL.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000250"
FT   CHAIN           28..4743
FT                   /note="Apolipoprotein B-100"
FT                   /id="PRO_0000293536"
FT   CHAIN           28..2146
FT                   /note="Apolipoprotein B-48"
FT                   /id="PRO_0000293537"
FT   DOMAIN          33..660
FT                   /note="Vitellogenin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
FT   REGION          29..113
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          219..293
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          890..947
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          2010..2145
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          3123..3198
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          3136..3146
FT                   /note="Basic (possible receptor binding region)"
FT                   /evidence="ECO:0000250"
FT   REGION          3336..3356
FT                   /note="LDL receptor binding"
FT                   /evidence="ECO:0000250"
FT   REGION          3346..3479
FT                   /note="Heparin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          3349..3357
FT                   /note="Basic (possible receptor binding region)"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         1973
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P04114"
FT   MOD_RES         2006
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         3981
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P04114"
FT   MOD_RES         3985
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04114"
FT   CARBOHYD        172
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        971
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1336
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1345
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1491
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2094
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2522
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2662
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2741
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2791
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2897
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2944
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3063
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3186
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3299
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3321
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3428
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3715
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3828
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4203
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4232
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        65..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
FT   DISULFID        173..199
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
FT   DISULFID        232..248
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
FT   DISULFID        372..377
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
FT   DISULFID        466..501
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
FT   DISULFID        954..964
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00557"
SQ   SEQUENCE   4743 AA;  536024 MW;  B01AD103F8EC5320 CRC64;
     MGPQRPALRA PLLLLFLLLF LDTSVWAQDA TRFKHLRKYV YSYEAESSSG VRGTADSRSA
     TKINCKVELE VPQVCTLIMR TSQCTLKEVY GFNPEGKALM KKTKNSEEFA SAMSRYELKL
     AFPEGKRVAL YPDLGEPNYI LNIKRGIISA LLVPPETEED KQVLFQDTVY GNCSTQVTVN
     SRKGTVATEM STERNLQHCD GFQPISTSVS PLALIKGLVR PLSTLISSSQ SCQYTLEPKR
     KHVSEAICNE QHLFLPFSYK NKYGIMTHVT QKLSLEDTPK INSRFFRGGI NQVGLAFEST
     KSTSPPKQAD AVLKTLQELK KLSISEQNAQ RANLFHKLVT ELRGLSGEAI TSLLPQLIEV
     SSPITLQALI QCGQPECYTH ILQWLKTEKA HPLLIDIVTY LMALIPNPSV QRLQEIFNTA
     KELQSRATLY ALSHAVNSYY AIMDHSRSPV LEDIAGYLMK QIDNECMGDE DRTFLILRVI
     GNMGRTMERV MPALKSSVLN CVRSTKPSLQ IQKAALQALR KMEMGDEVRT ILFDTFVNDV
     APVEKRLAAY LLLMRSPSSS DINKIAKLLQ WEQSEQVKNF VASHIANILN SEELYVQDLK
     NLIKNALVNS RLPTIMDFRK FSRNYQISKS VSIPLFDPVS AKIEGNLVFD PSSYLPKESM
     LKTTLTVFGI ASLDLFEIGL EGKGFEPTLE ALFGKQGFFP DSVNKALYWV NGQVPDRVSK
     VLVDHFGYTK DDKHEQDMVN GIMPIVDKLI KELKSKEIPE ARAYLRILGK ELGFVRLQDL
     QVLGKLLLNG AQTFRGVPQM IVQAIREGSK DDLFLHYIFM ENAFELPTGV GLQLQVSSSG
     VFTPGIKAGV RLELANIQAE LVAKPSVSLE FVTNMGIIIP DFAKSGVQMN TNFFHESGLE
     ARVALKAGQL KVIIPSPKRP VKLFSGSNTL HLVSTTKTEV IPPLIENRKS WSTCKPFFTG
     MNYCTTGAYS NASSTESASY YPLTGDTRYE LELKPTGEVE QYSASATYEL LKEDKSLVDT
     LKFLVQAEGV QQSEATAMFK YNRRSRTLSS EVLIPGFDVN FGTILRVNDE SSKDKNTYKL
     ILDIQNKKIT EVSVVGHVSY DKKGDGKVKG VVSIPRLQAE ARSEVHTHWS PTKLLFQMDS
     SATAYGSTIS KRVAWRYDNE KIEFDWNTGT NVDTKKVASN FPVDLSRYPR MVHEYANGLL
     DHRVPQTDMT FRHMGSKLIV DHLNGLSELN LPKVGLPDFH IPDNLFLKTD GRVKYTLNKN
     RIEIDIPLPL GGKSSKDLKV PESVRTPALN FKSVGFHLPS QEVQIPTFTI PKTHQLQVPL
     LGILDLSTNV YSNLYNWSVS YTGGNTSRDH FSLQAQYRMK ADSVVDLFSY SVQGSGETTY
     DSKSTFTLSC DGSLHHKFLD SKFKVSHVEK FGNNPVSKGL LTFETSSALG PQMSATVQLD
     SKKKQHLYVK DIKVDGQFRV FSLYAQGEYG LSYERDSMTG QMSGESNMKF NSTYFQGTNQ
     IVGMYQDGML SVTSTSDLQD GIFKNTASLK YENYELTLKS DSSGQYENFA ASNKLDMTFS
     KQSALLRSEH QANYKSLRLV TLLSGSLTSQ GVELNADILG TDKINTGAHK STLKIAQDGV
     STSATTNLKY SPLLLENELN AELGLSGASM KLSTSGRFKE HHAKFSLDGR AALTEVSLGS
     IYQAMILGAD SKNVFNFKLS REGLKLSNDM MGSYAEMKLD HTHSLRISGL SLDFFSKMDN
     IYSGDKFYKQ NFNLQLQPYS FGITLSNDLK YDALVLTNNG RLRLEPLKLN VGGNFKGTYQ
     NNELKHIYTI SYTDLVVASY RADTVATVQG VEFSHRLNAD IEGLASSVDV TTSYSSDPLH
     FNNVFRFVLA PFTLGVDTHT SGDGKMSLWG EHTGQMYSKF LLKAEPLALT FSHDYKGSTS
     HNLLYKNSVS TALEHTLSAL LTPAEQTSSW KFKTSLNDKV YSQEFEAYNT KDKIGIELSG
     RADLSGLYSP IKVPFFYSEP VNVLNSLEIN DAFDEPREFT IDAVVKYDKN QDVHTISLPF
     FQSLPDYLER NRRGIISLLE AMKGELQRLS VDQFVRKYRV ALSRLPQQIH DYLNASDWER
     QVAGAKEKLT SFMENYRITD NDVLIALDSA KINLNEKLSQ LETYAIQFDQ YIRDNYDAQD
     LKRTIAQIID RIIEKLKMLD EQYHIRVNLA KSIHNLYLFV ENVDLNQISS SGASWIQNVD
     TKYQIRIQIQ EKLQHLRTQI HNIDIQQLAA ELKQQIEALD VPMHLDQLRT AILFQRISVI
     IERVKYFVMN LIEDFKVTEK INTFRVIVRE LIEKYEVDRQ IQVLMDKSIE LAHRYSLSEP
     LQKLSNVLQQ IEIKDYYDKL VGFIDDTVEW IKAVSFKNII EELNRLIDMS VKKLKAFDYH
     QFVDKTNSKI REMTQRINAE IQALELPQKT EALKLWVEDF KTTVSNSLEK LKDTKVTVVV
     DWLQDGLAQI KAQFQDALED VRDRIYQMDI QGELERCLSL VSQVYSTVVT YISDWWTLTA
     KNITDFAEQY STQKWAESVK ALVEQGFIVP EIQTFLGTMP AFEVSLHALQ EANFQTPDFI
     VPLTDLRIPS IWINFKMLKN VKIPLRFSTP EFTLLNTFRV RSFTIDLLEI KAKIIRTIDQ
     MLSSELQWPL PEVYLRDLEM VNISLARLSL PDFHVPEITI PEFTIPNVNL KDLQVPDLHI
     PEFQLPHLSC TTEIPAFGKL HSVLKIQSPL FILDASANIQ NITTSENKAE IVASVTARGE
     SKFEALNFDF QAQAQFLELN ANPLVLKESV NFSSKHVRME HEGKILVSGK ALEGKSDTVA
     RLHTEKNTVE FNNGIVVKIN NQFTLDSQTK YFHKLSVPRL DFSSKASLNN EIKTLLEAGH
     MAWTSSGTGS WNWACPNFSD EGIHSSKISF IVDGPIASFG LSNNINGKHL RVVQKLTSES
     GFLNYSRFEV ESKVESQHVG SSILTAEGRA LLGDAKAEMT GEHNANLNGK VIGTLKNSLF
     FSAQPFEITA STNNEGNLKV SFPLKLTGKI DFLNNYALFL SPHAQQASWQ LSTRFNQYKY
     NQNFSAINNE HNMEASIVMN GDANLDFLNI PLTIPEINLP YTRFTTPLLK DFSIWEETGL
     KEFLKTTKQS FDLSIKAQYK KNRDKHSVVI PLKMFYEFML NNVNSWDRKF EKVRDNALHF
     LTASYNETKI KFDKYKTENS LNQPSRTFQN RGHTIPVLNI EVSPFAVETL ASSHVIPKAI
     RTPSVTIPGP NIIVPSYRLV LPSLQLPVFH IPRTLFKFSL PDFKKLSTID NIYIPAMGNF
     TYDFSFKSSV ITLNTNAGLY NQSDLVARFL SSSSFVTDAL QYKLEGTSRL MRKKVLKLAT
     AVSLTNKFLK GSHDSTISLT KKNMEASVKT TANLHAPIFT MNFKQELNGN TKSKPTVSSS
     IELNYDFNSS KLHSAAKGGV DHKFSLESLT SYLSIESFTK GNIKGSFLSQ EYSGSVANEA
     NVYLNSKGTR SSVRLQGASN FAGIWNFEVG ENFAGEATLR RIYGTWEHNM INHLQVFSYF
     DTKGKQTCRA TLELSPWTMS TLLQVHVSQP SPLFDLHHFD QEVILKASTK NQKVSWKSEV
     QVESQVLQHN AHFSNDQEEV RLDIAGSLEG QLWDLENFFL PAFGKSLREL LQIDGKRQYL
     QASTSLHYTK NPNGYLLSLP VQELTDRFII PGLKLNDFSG IKIYKKLSTS PFALNLTMLP
     KVKFPGVDLL TQYSKPEGSS VPTFETTIPE IQLTVSQFTL PKSFPVGNTV FDLNKLTNLI
     ADVDLPSITL PEQTIEIPSL EFSVPAGIFI PFFGELTAHV GMASPLYNVT WSTGWKNKAD
     HVETFLDSTC SSTLQFLEYA LKVVGTHRIE NDKFIYKIKG TLQHCDFNVK YNEDGIFEGL
     WDLEGEAHLD ITSPALTDFH LHYKEDKTSV SASAASPAIG TVSLDASTDD QSVRLNVYFR
     PQSPPDNKLS IFKMEWRDKE SDGETYIKIN WEEEAAFRLL DSLKSNVPKA SEAVYDYVKK
     YHLGHASSEL RKSLQNDAEH AIRMVDEMNV NAQRVTRDTY QSLYKKMLAQ ESQSIPEKLK
     KMVLGSLVRI TQKYHMAVTW LMDSVIHFLK FNRVQFPGNA GTYTVDELYT IAMRETKKLL
     SQLFNGLGHL FSYVQDQVEK SRVINDITFK CPFSPTPCKL KDVLLIFRED LNILSNLGQQ
     DINFTTILSD FQSFLERLLD IIEEKIECLK NNESTCVPDH INMFFKTHIP FAFKSLRENI
     YSVFSEFNDF VQSILQEGSY KLQQVHQYMK AFREEYFDPS VVGWTVKYYE IEEKMVDLIK
     TLLAPLRDFY SEYSVTAADF ASKMSTQVEQ FVSRDIREYL SMLADINGKG REKVAELSIV
     VKERIKSWST AVAEITSDYL RQLHSKLQDF SDQLSGYYEK FVAESTRLID LSIQNYHMFL
     RYIAELLKKL QVATANNGLL KRGDFEAAVK LGIACLYNEG LSVSDEAYAE VNGLKASRFF
     SMDERLNMGS DPFIWLSICP PCFRKLRDFA GKGCWEAQPA LAKDCAGGSQ LGLEGKAFSE
     SVCQLFQASQ AVNKQQIFSV QKGLSDTVRY ILIGWLVEVA PMKDFTSLCL HLTVECVGRY
     LQRKLVPRYK LQLLGIACMV ICTWFISKEI LTIREAVRLT DNTYKYKDLV RVKREIISAL
     EGKIRIPTVV DYKEVLLTLV PVTPRTQYLC SFLCELTLSV YTPAHLASAA LLLARLMHGQ
     TQP
//
